✦ LIBER ✦

Hydralazine and magnesium valproate as epigenetic treatment for myelodysplastic syndrome. Preliminary results of a phase-II trial

✍ Scribed by Myrna Candelaria; Aquileo Herrera; Juan Labardini; Aurora González-Fierro; Catalina Trejo-Becerril; Lucía Taja-Chayeb; Enrique Pérez-Cárdenas; Erick de la Cruz-Hernández; Daymi Arias-Bofill; Silvia Vidal; Eduardo Cervera; Alfonso Dueñas-Gonzalez

Book ID: 105989732
Publisher: Springer
Year: 2010
Tongue: English
Weight: 221 KB
Volume: 90
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-010-1090-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A double-blind, placebo-controlled, rand

A double-blind, placebo-controlled, randomized phase III trial of chemotherapy plus epigenetic therapy with hydralazine valproate for advanced cervical cancer. Preliminary results

✍ Jaime Coronel; Lucely Cetina; Irlanda Pacheco; Catalina Trejo-Becerril; Aurora G 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 210 KB

Preliminary Results Of A Phase II Trial

Preliminary Results Of A Phase II Trial Of Montelukast For The Treatment Of Bronchiolitis Obliterans Syndrome After HSCT

✍ K.M. Williams; S.Z. Pavletic; F.T. Hakim; S.A. Mitchell; J.C. Gea-Banacloche; L. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Preliminary Results of a Phase II Trial

Preliminary Results of a Phase II Trial of Montelukast for the Treatment of Bronchiolitis Obliterans Syndrome After HSCT

✍ K.M. Williams; S.Z. Pavletic; F.T. Hakim; S.A. Mitchell; J.C. Gea-Banacloche; L. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 62 KB

A phase-II trial of alltransretinoic aci

A phase-II trial of alltransretinoic acid and low-dose cytosine arabinoside for the treatment of high-risk myelodysplastic syndromes

✍ A. Venditti; A. Tamburini; F. Buccisano; M. T. Scimò; G. Del Poeta; L. Maurillo; 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 78 KB

High-dose darbepoetin alpha in the treat

High-dose darbepoetin alpha in the treatment of anaemia of lower risk myelodysplastic syndrome results of a phase II study

✍ L. Mannone; C. Gardin; M. C. Quarre; J. F. Bernard; D. Vassilieff; L. Ades; S. P 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

466 PUBLICATION A phase II trial of gemc

466 PUBLICATION A phase II trial of gemcitabine (G) and doxorubicin (D) combination as first line treatment of metastatic breast cancer: preliminary results

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 136 KB